<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12737/article_5955e6b4c2a202.26751657</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-361</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>ДИФФЕРЕНЦИРОВАННОЕ КОМПЛЕКСНОЕ ЛЕЧЕНИЕ ПАЦИЕНТОВ, СТРАДАЮЩИХ БОЛЕЗНЬЮ ПАРКИНСОНА, С УЧЁТОМ СТЕПЕНИ АТРОФИЧЕСКИХ ИЗМЕНЕНИЙ ВЕЩЕСТВА ГОЛОВНОГО МОЗГА</article-title><trans-title-group xml:lang="en"><trans-title></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чипизубов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chipizubov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">chipizubov.neuro@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петров</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrov</surname><given-names>S. I.</given-names></name></name-alternatives><email xlink:type="simple">petrov_si@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михалевич</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhalevich</surname><given-names>I. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутская государственная медицинская академия последипломного образования - филиал ФГБОУ «Российская медицинская академия непрерывного профессионального образования» Минздрава России; ГБУЗ «Иркутская ордена «Знак почёта» областная клиническая больница»</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Russian Medical Academy of Continuing Professional Education; Irkutsk Regional Clinical Hospital</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Иркутская ордена «Знак почёта» областная клиническая больница»</institution></aff><aff xml:lang="en"><institution>Irkutsk Regional Clinical Hospital</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Иркутская государственная медицинская академия последипломного образования - филиал ФГБОУ «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education - Branch Campus of the Russian Medical Academy of Continuing Professional Education</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2017</year></pub-date><volume>2</volume><issue>1</issue><fpage>48</fpage><lpage>51</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чипизубов В.А., Петров С.И., Михалевич И.М., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Чипизубов В.А., Петров С.И., Михалевич И.М.</copyright-holder><copyright-holder xml:lang="en">Chipizubov V.A., Petrov S.I., Mikhalevich I.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/361">https://www.actabiomedica.ru/jour/article/view/361</self-uri><abstract><p>Сравнивались результаты комплексного (медикаментозного и хирургического) и медикаментозного лечения пациентов с быстропрогрессирующей и ассоциированной с дискинезиями формой болезни Паркинсона. Предложены индексы атрофии (ИА) вещества головного мозга для обоснования дифференцированного подхода в лечении каждой из форм. По результатам многофакторного регрессионного анализа определены значения, при которых эффект комплексного лечения максимальный. Также определены значения ИА, при которых результат был практически постоянным в течение 1,5 лет наблюдения.</p></abstract><trans-abstract xml:lang="en"><p>The objective of this study was to compare the results of complex (medicinal and surgical), and only medicinal treatment of patients with rapidly progressive and dyskinesia associated forms of Parkinson's disease. Three atrophy indices (IA) of the brain matter were proposed to justify a differentiated approach to the treatment of each form. Multivariable regression analysis showed, that patients, who were treated with complex method and had IA-1 less than 0.16, IA-2 - less than 0.115, IA-3 - less than 0.06, had the best improvement of the clinical status during the follow-up period. There were also multiple correlation coefficients obtained in the range 0.911-0.943, which indicates a significant linear relationship between the factors of influence (IA) and response (clinical presentation). In groups with only conservative treatment, the coefficients were in the range of 0.331-0, 423, indicating low and medium dependence on clinical manifestations of atrophy indexes. The status of all patients was assessed after 3, 6, 12 and 18 months. It turned out that in case of the earlier mentioned indices values the result of the treatment was constant during the entire period of observation. It was statistically confirmed by the assessment of the squares of the Mahalanobis distance.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>болезнь Паркинсона</kwd><kwd>дискинезия</kwd><kwd>индекс атрофии</kwd><kwd>стереотаксическая деструкция</kwd><kwd>нейродегенеративное заболевание</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Parkinson's disease</kwd><kwd>dyskinesia</kwd><kwd>atrophy index</kwd><kwd>stereotactic destruction</kwd><kwd>neurodegenerative disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">исследованиях с применением ППП Statistica): пособие для врачей. -Иркутск: РИО ГБОУ ДПО ИГМАПО, 2015. - 44 с.</mixed-citation><mixed-citation xml:lang="en">исследованиях с применением ППП Statistica): пособие для врачей. -Иркутск: РИО ГБОУ ДПО ИГМАПО, 2015. - 44 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Михалевич И.М. Регрессионный анализ (использование в медицинских исследованиях с применением ППП Statistica): пособие для врачей. - Иркутск: РИО ИГИУВа, 2009. - 32 с.</mixed-citation><mixed-citation xml:lang="en">Михалевич И.М. Регрессионный анализ (использование в медицинских исследованиях с применением ППП Statistica): пособие для врачей. - Иркутск: РИО ИГИУВа, 2009. - 32 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Саютина С.Б., Шпрах В.В., Рожкова Н.Ю. Цитиколин в комплексной терапии болезни Паркинсона // Тихоокеанский медицинский журнал. - 2013. -№ 4. - С. 76-78.</mixed-citation><mixed-citation xml:lang="en">Саютина С.Б., Шпрах В.В., Рожкова Н.Ю. Цитиколин в комплексной терапии болезни Паркинсона // Тихоокеанский медицинский журнал. - 2013. -№ 4. - С. 76-78.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Саютина С.Б., Шпрах В.В. Возможности комплексной коррекции немоторных проявлений болезни Паркинсона в сочетании с дисциркуляторной энцефалопатией // Матер. II нац. конгр. по болезни Паркинсона и двигательным расстройствам. - М., 2011. - С. 359-363.</mixed-citation><mixed-citation xml:lang="en">Саютина С.Б., Шпрах В.В. Возможности комплексной коррекции немоторных проявлений болезни Паркинсона в сочетании с дисциркуляторной энцефалопатией // Матер. II нац. конгр. по болезни Паркинсона и двигательным расстройствам. - М., 2011. - С. 359-363.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Coban A., Hanagasi H.A., Karamursel S., Barlas O.B. (2009). Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson’s disease. J. Neurosurg., 23 (1), 23-29. doi: 10.1080/02688690802507775.</mixed-citation><mixed-citation xml:lang="en">Coban A., Hanagasi H.A., Karamursel S., Barlas O.B. (2009). Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson’s disease. J. Neurosurg., 23 (1), 23-29. doi: 10.1080/02688690802507775.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Guridi J.I., Obeso J.A., Rodriguez-Oroz M.C., Lozano A.A., Manrique M. (2008). L-dopa-induced dyskinesia and stereotactic surgery for Parkinson’s disease. Neurosurgery, 62 (2), 311-323, discussion 323-5. doi: 0.1227/01.neu.0000315998.58022.55.</mixed-citation><mixed-citation xml:lang="en">Guridi J.I., Obeso J.A., Rodriguez-Oroz M.C., Lozano A.A., Manrique M. (2008). L-dopa-induced dyskinesia and stereotactic surgery for Parkinson’s disease. Neurosurgery, 62 (2), 311-323, discussion 323-5. doi: 0.1227/01.neu.0000315998.58022.55.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jourdain V.A., Schechtmann G., Di Paolo T. (2014). Subthalamotomy in the treatment of Parkinson’s disease: clinical aspects and mechanisms of action. J. Neurosurg., 120 (1), 140-151. doi: 10.3171/2013.10.JNS13332.</mixed-citation><mixed-citation xml:lang="en">Jourdain V.A., Schechtmann G., Di Paolo T. (2014). Subthalamotomy in the treatment of Parkinson’s disease: clinical aspects and mechanisms of action. J. Neurosurg., 120 (1), 140-151. doi: 10.3171/2013.10.JNS13332.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Munhoz R.P., Cerasa A., Okun M.S. (2014). Surgical treatment of dyskinesia in Parkinson’s disease. Front. Neurol., 29 (5), 65. doi: 10.3389/fneur.2014.00065.</mixed-citation><mixed-citation xml:lang="en">Munhoz R.P., Cerasa A., Okun M.S. (2014). Surgical treatment of dyskinesia in Parkinson’s disease. Front. Neurol., 29 (5), 65. doi: 10.3389/fneur.2014.00065.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Obeso J.A., Jahanshahi M., Alvarez L., Macias R., Pedroso I., Wilkinson L., Rothwell J.C. (2009). What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson’s disease. Exp. Neurol., 220 (2), 283-292. doi: 10.1016/j.expneurol.2009.08.030.</mixed-citation><mixed-citation xml:lang="en">Obeso J.A., Jahanshahi M., Alvarez L., Macias R., Pedroso I., Wilkinson L., Rothwell J.C. (2009). What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson’s disease. Exp. Neurol., 220 (2), 283-292. doi: 10.1016/j.expneurol.2009.08.030.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sako W., Miyazaki Y., Izumi Y., Kaji R. (2014). Which target is best for patients with Parkinson’s disease. A meta-analysis of pallidal and subthalamic stimulation. J. Neurol. Neurosurg. Psychiatry, 85 (9), 982-986. doi: 10.1136/jnnp-2013-306090.</mixed-citation><mixed-citation xml:lang="en">Sako W., Miyazaki Y., Izumi Y., Kaji R. (2014). Which target is best for patients with Parkinson’s disease. A meta-analysis of pallidal and subthalamic stimulation. J. Neurol. Neurosurg. Psychiatry, 85 (9), 982-986. doi: 10.1136/jnnp-2013-306090.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tarsy D. (2009). Does subthalamotomy have a place in the treatment of Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry, 80 (9), 939-940. doi: 10.1136/ jnnp.2008.163949.</mixed-citation><mixed-citation xml:lang="en">Tarsy D. (2009). Does subthalamotomy have a place in the treatment of Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry, 80 (9), 939-940. doi: 10.1136/ jnnp.2008.163949.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
